Galapagos N.V.

Galapagos N.V.verified

GLPG

Price:

$27.98

Market Cap:

$1.64B

Galapagos NV functions as an integrated biopharmaceutical enterprise, concentrating its efforts on identifying, developing, and marketing a diverse range of medications aimed at critical unaddressed medical conditions. The company's comprehensive pipeline includes several significant experimental therapies. Leading this portfolio is filgotinib, a JAK1 inhibitor that is currently progressing through various clinical trial phases for the management of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel Crohn's disease, fistulizing Crohn's disease, ankylosing spondylitis, psoriatic arthritis, and uveitis. Additionally, their developmental assets feature GLPG1972, which has su...[Read more]

Industry

Biotechnology

IPO Date

2012-02-27

Stock Exchange

NASDAQ

Ticker

GLPG

The ROE as of June 2026 (TTM) for Galapagos N.V. (GLPG) is 16.88%

According to Galapagos N.V.’s latest financial reports and current stock price. The company's current ROE is 16.88%. This represents a change of 446.52% compared to the average of 3.09% of the last 4 quarters.

Galapagos N.V. (GLPG) Historical ROE (quarterly & annually)

How has GLPG ROE performed in the past?

The mean historical ROE of Galapagos N.V. over the last ten years is 9.92%. The current 16.88% ROE has changed 70.26% with respect to the historical average. Over the past ten years (40 quarters), GLPG's ROE was at its highest in in the December 2025 quarter at 24.17%. The ROE was at its lowest in in the September 2025 quarter at -8.26%.

Quarterly (TTM)
Annual

Average

9.92%

Median

9.92%

Minimum

9.92%

Maximum

9.92%

Galapagos N.V. (GLPG) ROE by Quarter and Year

Discovering the peaks and valleys of Galapagos N.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 9.92%

Minimum Annual Increase = 0%

Minimum Annual ROE = 9.92%

Quarterly (TTM)
Annual
YearROEChange

Galapagos N.V. (GLPG) Average ROE

How has GLPG ROE performed in the past?

The current ROE of Galapagos N.V. (GLPG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

9.92%

5-year avg

9.92%

10-year avg

9.92%

Galapagos N.V. (GLPG) ROE vs. Peers

How is GLPG’s ROE compared to its peers?

Galapagos N.V.’s ROE is greater than Arcus Biosciences, Inc. (-68.97%), greater than Ocular Therapeutix, Inc. (-64.55%), less than ImmunityBio, Inc. (138.69%), greater than Viridian Therapeutics, Inc. (-60.70%), greater than Cogent Biosciences, Inc. (-83.29%), greater than Denali Therapeutics Inc. (-52.20%), greater than uniQure N.V. (-145.81%), greater than 89bio, Inc. (-59.12%), greater than Structure Therapeutics Inc. (-15.14%), greater than Mesoblast Limited (-14.02%),

Build a custom stock screener for Galapagos N.V. (GLPG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galapagos N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galapagos N.V. (GLPG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galapagos N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Galapagos N.V.'s ROE?

How is the ROE calculated for Galapagos N.V. (GLPG)?

What is the highest ROE for Galapagos N.V. (GLPG)?

What is the 3-year average ROE for Galapagos N.V. (GLPG)?

What is the 5-year average ROE for Galapagos N.V. (GLPG)?

How does the current ROE for Galapagos N.V. (GLPG) compare to its historical average?